Glioblastoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas
Active, not recruiting
  • High Grade Glioma
  • +3 more
  • Regadenoson 0.05mg
  • +6 more
  • Birmingham, Alabama
  • +2 more
2022-04-07
Apr 7, 2022
N
Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma
Recruiting
  • Gliosarcoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
G
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Recruiting
  • Glioblastoma
  • Birmingham, Alabama
  • +47 more
2022-04-06
Apr 6, 2022
I
INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
Active, not recruiting
  • Glioblastoma
  • INO-5401
  • +4 more
  • Duarte, California
  • +20 more
2022-04-06
Apr 6, 2022
N
Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)
Active, not recruiting
  • Glioblastoma
  • Los Angeles, California
  • +13 more
2022-04-07
Apr 7, 2022
B
Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Recruiting
  • Glioblastoma
  • MGMT-Unmethylated Glioblastoma
  • Microtubule-Targeted Agent BAL101553
  • +3 more
  • Birmingham, Alabama
  • +7 more
2022-03-31
Mar 31, 2022
M
Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI - 2022
Completed
  • Glioblastoma
  • Avastin
  • +5 more
  • Boston, Massachusetts
    Massachusetts general Hospital
2022-04-06
Apr 6, 2022
U
TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma - 2021
Terminated
  • Glioblastoma Multiforme
  • +3 more
  • Gainesville, Florida
  • +1 more
2022-03-31
Mar 31, 2022
N
Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
Recruiting
  • Glioblastoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations
Recruiting
  • Advanced Malignant Solid Neoplasm
  • +6 more
  • Costa Mesa, California
  • +49 more
2022-04-06
Apr 6, 2022
N
A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.
Not yet recruiting
  • Glioblastoma
  • (no location specified)
2022-04-05
Apr 5, 2022
N
Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
Recruiting
  • Glioblastoma
  • Gliosarcoma
  • Littleton, Colorado
  • +37 more
2022-04-04
Apr 4, 2022
S
A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
Active, not recruiting
  • Glioblastoma
  • Birmingham, Alabama
  • +60 more
2022-04-04
Apr 4, 2022
S
A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma - 2019
Completed
Has Results
  • Glioblastoma
  • New York, New York
  • +2 more
2022-04-04
Apr 4, 2022
M
Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma
Recruiting
  • Glioblastoma
  • +2 more
  • External Beam Radiation Therapy
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
2022-04-04
Apr 4, 2022
C
In Situ Immune Parameters and Their Prognostic Role on the Survival of Patients With Glioblastoma
Recruiting
  • Glioblastoma
    • Dijon, France
    • +4 more
    2022-03-24
    Mar 24, 2022
    W
    Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma
    Recruiting
    • Glioblastoma
    • Personalized neoantigen DNA vaccine supplied by Geneos Therapeutics
    • +2 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    2022-03-21
    Mar 21, 2022
    S
    SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
    Recruiting
    • Anaplastic Astrocytoma
    • +55 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    2022-04-01
    Apr 1, 2022
    S
    ONC206 for Treatment of Newly Diagnosed, or Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant Brain Tumors (PNOC 023)
    Recruiting
    • Diffuse Midline Glioma (DMG)
    • +6 more
    • ONC206
    • Standard of Care Radiation Therapy
    • San Francisco, California
    • +2 more
    2022-03-30
    Mar 30, 2022
    T
    Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
    Recruiting
    • Ependymoma
    • +3 more
    • Augusta, Georgia
      Augusta University, Georgia Cancer Center
    2022-03-20
    Mar 20, 2022
    S
    Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG
    Active, not recruiting
    • High Grade Glioma
    • +6 more
    • Birmingham, Alabama
    • +5 more
    2022-03-31
    Mar 31, 2022
    A
    Personalized Radiation Therapy for GBM
    Recruiting
    • Glioblastoma
    • Radation Therapy
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    2022-03-31
    Mar 31, 2022
    P
    Safety and Efficacy of Different Administration Sequences of L19TNF With Lomustine in Glioblastoma at First Progression
    Not yet recruiting
    • Glioblastoma
    • (no location specified)
    2022-03-30
    Mar 30, 2022
    N
    Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer
    Recruiting
    • Glioblastoma
    • +3 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Birmingham, Alabama
    • +9 more
    2022-03-30
    Mar 30, 2022
    X
    Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab
    Recruiting
    • Glioblastoma
    • +3 more
    • Radiation: Intra-operative Radiation Therapy - IORT
    • +2 more
    • Santa Monica, California
      Providence Saint John's Health Center
    2022-03-30
    Mar 30, 2022